http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015516447-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate | 2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2015516447-A |
titleOfInvention | (1r, 4r) -6′-Fluoro-N, N-dimethyl-4-phenyl-4 ′, 9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano- [3,4, b ] A pharmaceutical composition comprising indole] -4-amine and a propionic acid derivative |
abstract | The present invention relates to (1r, 4r) -6′-fluoro-N, N-dimethyl-4-phenyl-4 ′, 9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano [3, A first pharmacologically active ingredient selected from 4, b] indole] -4-amine and physiologically acceptable salts thereof, ibuprofen, naproxen, ketoprofen, flurbiprofen, fenoprofen, fenbufen, suprofen, A second pharmacology that is a propionic acid derivative selected from the group consisting of pyrprofen, indoprofen, thiaprofenic acid, oxaprozin, ibuproxam, flunoxaprofen, aluminoprofen, naproxinodo, and physiologically acceptable salts thereof. The present invention relates to a pharmaceutical composition comprising an active ingredient. |
priorityDate | 2012-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.